Mintz, Levin, Cohn, Ferris, Glovsky and Popeo advised Intensity Therapeutics, while Sullivan & Worcester advised the placement agents in the offering. Intensity Therapeutics, Inc. (Nasdaq: INTS)...
You must be a Standard 1 Year member to access this content.
Sullivan & Worcester advised Swvl Holdings Corp. on the offering. Swvl Holdings Corp., a UAE-based leading provider of technology-driven mobility solutions for enterprises and governments in...
You must be a Standard 1 Year member to access this content.
Lowenstein Sandler advised Sonnet BioTherapeutics, while Sullivan & Worcester advised Chardan Capital Markets on the offering. Sonnet BioTherapeutics Holdings, Inc. (Nasdaq: SONN), a clinical-stage company developing...
You must be a Standard 1 Year member to access this content.
Sullivan & Worcester advised A.G.P./Alliance Global Partners on the offering. Palladyne AI Corp. (Nasdaq: PDYN and PDYNW), a developer of artificial intelligence software for robotic platforms...
You must be a Standard 1 Year member to access this content.
Locke Lord advised Professional Diversity Network, while Sullivan & Worcester represented A.G.P./Alliance Global Partners in the offering. Professional Diversity Network, Inc. (NASDAQ: IPDN) has entered into...
You must be a Standard 1 Year member to access this content.
Dorsey & Whitney advised Shuttle Pharmaceuticals, while Sullivan & Worcester advised A.G.P./Alliance Global Partners in the offering. Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) announced the pricing...
You must be a Standard 1 Year member to access this content.
ArentFox Schiff advised CNS Pharmaceuticals, while Sullivan & Worcester advised A.G.P./Alliance Global Partners on the offering. CNS Pharmaceuticals, Inc. closed the $3 million registered direct offering...
You must be a Standard 1 Year member to access this content.
Sullivan & Worcester represented A.G.P./Alliance Global Partners in the transaction. XORTX Therapeutics has entered into securities purchase agreements with institutional investors for the purchase and sale...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised BioCardia, while Sullivan & Worcester advised A.G.P./Alliance Global Partners on the offering. BioCardia, Inc. (Nasdaq: BCDA) completed its $7.2 million...
You must be a Standard 1 Year member to access this content.
Sullivan & Worcester advised A.G.P./Alliance Global Partners on the offering. Gorilla Technology Group, Inc. (Nasdaq: GRRR) executed a $12 million offering of ordinary shares and warrants....
You must be a Standard 1 Year member to access this content.
Sullivan & Worcester advised A.G.P./Alliance Global Partners on the offering. Soligenix, Inc. (Nasdaq: SNGX) $4.75 million public offering of common stock and warrants, consisting of 11,875,000...
You must be a Standard 1 Year member to access this content.
Lowenstein Sandler represented Matinas BioPharma, while Sullivan & Worcester represented A.G.P./Alliance Global Partners in the offering. Matinas BioPharma Holdings, Inc. (NYSE American: MTNB) entered into securities purchase...
You must be a Standard 1 Year member to access this content.
